Literature DB >> 9574514

Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies.

D Smith1, S Sieg, D Kaplan.   

Abstract

Polyclonal rabbit Abs raised against peptides from the C-terminal region (the extracellular domain) of human Fas ligand were produced for the detection of the molecule in Western blot analysis and immunohistochemistry. These Abs have been used by several groups of investigators to assess cell surface Fas ligand via flow cytometry, but we show that these polyclonal rabbit Abs do not detect cell surface Fas ligand by that technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574514

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.

Authors:  N P Restifo
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  Human melanoma cells do not express Fas (Apo-1/CD95) ligand.

Authors:  D B Chappell; T Z Zaks; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

3.  Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.

Authors:  T Z Zaks; D B Chappell; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus.

Authors:  J Baran; K Weglarczyk; M Mysiak; K Guzik; M Ernst; H D Flad; J Pryjma
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 5.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

Review 6.  CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Authors:  J Sträter; P Möller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

7.  Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.

Authors:  Dominique Chopin; Reza Barei-Moniri; Pascale Maillé; Marie-Aude Le Frère-Belda; Béatrice Muscatelli-Groux; Nicolò Merendino; Laure Lecerf; Antonella Stoppacciaro; Francesca Velotti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

8.  The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells.

Authors:  D Fishman; B Irena; S Kellman-Pressman; M Karas; S Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

9.  Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells.

Authors:  Victor M Campa; Robert M Kypta
Journal:  Biol Direct       Date:  2011-01-24       Impact factor: 4.540

10.  Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.

Authors:  G B Ragnarsson; E K Mikaelsdottir; H Vidarsson; J G Jónasson; K Olafsdóttir; K Kristjánsdóttir; J Kjartansson; H M Ogmundsdóttir; T Rafnar
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.